Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 258 | 244 | -15 | 234 | 183 |
| Gross Profit | 258 | 244 | -15 | 234 | 183 |
| Operating Expenses | 20,311 | 16,048 | 14,480 | 15,354 | 14,410 |
| Operating Income | -20,053 | -15,804 | -14,495 | -15,120 | -14,227 |
| Other Income | 636 | 709 | 860 | 1,031 | 1,273 |
| Pre-tax Income | -19,417 | -15,095 | -13,635 | -14,089 | -12,954 |
| Income Tax | N/A | N/A | -14 | N/A | 7 |
| Net Income Continuous | -19,417 | -15,095 | -13,621 | -14,089 | -12,961 |
| Net Income | $-19,417 | $-15,095 | $-13,635 | $-14,089 | $-12,961 |
| EPS Basic Total Ops | -0.54 | -0.47 | -0.44 | -0.46 | -0.42 |
| EPS Basic Continuous Ops | -0.54 | -0.47 | -0.43 | -0.46 | -0.42 |
| EPS Diluted Total Ops | -0.54 | -0.47 | -0.44 | -0.46 | -0.42 |
| EPS Diluted Continuous Ops | -0.54 | -0.47 | -0.43 | -0.46 | -0.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.47 | -0.43 | -0.46 | -0.42 |
| EBITDA(a) | $-20,145 | $-15,889 | $-14,583 | $-15,183 | $-14,330 |